Posters

Surgical approach in cases of paediatric cataract with trematodal granulomatous uveitis

Poster Details

First Author: M.Farouk EGYPT

Co Author(s):                        

Abstract Details

Purpose:

To describe the preoperative and intraoperative difficulties and complications encountered in cases of pediatric cataract with trematodal granulomatous uveitis in Egypt.

Setting:

Ophthalmology department, Sohag University Hospital, Egypt.

Methods:

Prospective, non-comparative, interventional case series included 12 cases of pediatric cataract with trematodal granulomatous anterior uveitis in the membranous (not active) stage were included in this study. Any cases with pearl-like lesion or active anterior uveitis were excluded. All cases were evaluated and prepared for phacoemulsification and operated under general anesthesia. Any special difficulties in preoperative evaluation and specific intraoperative or postoperative complications were reported. All cases were followed for 6 months.

Results:

All cases were males with age range from 7 to 13 year. All cases were characterized by flattened inferior corneal surface, the presence of irido-corneal and irido-lenticular adhesions, and poor dilatability of the pupil. The main difficulties in surgery were the poor dilatability of the pupil and the presence of fibrovascular membrane attached to the cornea, iris and lens capsule. Intraoperative hyphemea was reported in 3 cases. Two cases (16.6 %) were presented by postoperative fibrinous reaction which responds will to topical steroid treatment. Posterior capsule opacification was reported in 7 cases (58.3 %).

Conclusions:

Modifications to the standard phacoemulsification technique enabled safe and successful completion of the surgery in these cases. Precautions include; selecting cases in the inactive stage of uveitis, preparing the operative theatre with instruments used to dilate the pupil, avoid manipulation of the fibrovascular membrane, performing posterior capsulotomy and subconjunctival steroid injection at the end of surgery.

Financial Disclosure:

None